Literature DB >> 15271510

Effect of cadmium on ferredoxin:NADP+ oxidoreductase activity.

Joanna Grzyb1, Andrzej Waloszek, Dariusz Latowski, Stanisław Wieckowski.   

Abstract

Ferredoxin:NADP(+) oxidoreductase (FNR) was treated with cadmium and after that its diaphorase reaction in the presence of dibromothymoquinone (DBMIB) or ferricyanide (FeCy, K(3)Fe(CN)(6)) was examined. CdSO(4) (5 mM) caused 50% inhibition after half hour incubation. At least two components were distinguishable in the time-course inhibition, suggesting that more than one amino acid residues were engaged in reaction with the metal ion. The Lineweaver-Burk plots indicate that Cd(2+) is an uncompetitive inhibitor for DBMIB reduction but exerts non-competitive inhibition for the NADPH oxidation. The FeCy reduction did not follow Michaelis-Menten kinetics. Zn(2+) diminished inhibitory effect of Cd(2+) on the DBMIB reduction but enhanced inhibition of the FeCy reduction. Incubation with additional chelator (beta-mercaptoethanol, or histidine) abolished inhibitory effect of Cd(2+) on the FeCy reduction but not on the DBMIB reduction. The mode of Cd(2+) action on the diaphorase activity of FNR in the presence of DBMIB or FeCy is briefly discussed with the special reference to the implication of two distinct sites at the FNR molecule, which might be involved in the reduction of various non-physiological substrates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271510     DOI: 10.1016/j.jinorgbio.2004.04.004

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  1 in total

1.  Similarities and Differences in the Effects of Toxic Concentrations of Cadmium and Chromium on the Structure and Functions of Thylakoid Membranes in Chlorella variabilis.

Authors:  Ottó Zsiros; Gergely Nagy; Roland Patai; Katalin Solymosi; Urs Gasser; Tamás F Polgár; Győző Garab; László Kovács; Zsolt Tibor Hörcsik
Journal:  Front Plant Sci       Date:  2020-07-07       Impact factor: 5.753

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.